Corpus ID: 14363948

Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts.

@article{Hu1996MinibodyAN,
  title={Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts.},
  author={S. Hu and L. Shively and A. Raubitschek and M. Sherman and L. Williams and J. Wong and J. Shively and A. Wu},
  journal={Cancer research},
  year={1996},
  volume={56 13},
  pages={
          3055-61
        }
}

• S. Hu, L. Shively, +5 authors A. Wu
• Published 1996
• Chemistry, Medicine
• Cancer research

A novel engineered antibody fragment (VL-VH-CH3, or "minibody") with bivalent binding to carcinoembryonic antigen (CEA) was produced by genetic fusion of a T84.66 (anti-CEA) single-chain antibody (scFv) to the human IgG1 CH3 domain. Two designs for the connecting peptide were evaluated. In the T84.66/212 LD minibody, a two-amino acid linker (generated by fusion of restriction sites) was used to join VH and CH3. In the T84.66/212 Flex minibody, the human IgG1 hinge plus an additional 10 residues… Expand

View on PubMed

cancerres.aacrjournals.org

Save to Library

Create Alert

Cite

Launch Research Feed